急性ST段抬高型心肌梗死溶栓治疗专家共识
Expert consensus on thrombolytic therapy for ST-segment elevation myocardial infarction
江苏省医学会心血管病学分会 江苏省医师协会心血管内科医师分会 江苏省医师协会心脏重症专业委员会 江苏省医学会心血管病学分会基础与药物学组 李春坚 马根山 徐标 孔祥清
摘要
溶栓治疗是急性ST段抬高型心肌梗死(STEMI)最重要的救治措施之一.2018年国内发布了《ST段抬高型急性心肌梗死院前溶栓治疗中国专家共识》,极大地推动和指导了 STEMI的院前溶栓策略.近年来,国内外关于STEMI的溶栓治疗策略、溶栓患者的抗血小板、抗凝治疗、溶栓结合经皮冠状动脉介入治疗(PCI)策略、新冠疫情下再灌注策略等方面涌现了众多研究进展和循证证据.本共识旨在总结近年STEMI溶栓治疗领域的研究进展,并据此编定一套符合我国实际情况、临床指导性强的STEMI溶栓治疗专家共识,以期进一步优化STEMI救治流程和治疗策略,为提高STEMI患者救治成功率、改善患者长期预后做出贡献.
Abstract
Thrombolytic therapy plays a vital role in reperfusion strategy for ST-segment elevation myocardial infarction(STEMI)patients.Previous Chinese expert consensus focused on pre-hospital thrombolysis therapy in STEMI patients was published in 2018 which tremendously promoted pre-hospital thrombolysis therapy.In recent years,plenty of research progress and results of clinical trials have been released in following areas such as STEMI reperfusion strategy,anti-platelet/anti-coagulants therapy,contemporary facilitated percutaneous coronary intervention,and so on.Meanwhile,the COVID-19 pandemic makes timely reperfusion for STEMI patients even more challenging.Therefore,this consensus has been proposed aiming to summarize recent progress in STEMI thrombolysis therapy and to provide practical & evidence-based instructions conforming to national conditions.We hope this consensus will contribute to the emergency management and long-term prognosis of STEMI patients.
关键词
心肌梗死/溶栓/专家共识Key words
Myocardial infarction/Thrombolytic therapy/Expert consensus引用本文复制引用
基金项目
江苏省重点研发计划支持项目(BE2019754)
出版年
2024
NETL
NSTL
万方数据